Position in LNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,572,143
+$1,770,257 QoQ
Shares Held
23,185
+119.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#142
of 462 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $20,925,728 across 13 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
135,900 | $9,765,774 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
284,488 | $2,796,517 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
This page
|
23,185 | $2,572,143 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,320 | $2,340,705 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
39,791 | $1,440,434 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
74,074 | $740,740 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,930 | $336,428 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
9,137 | $316,779 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,572,143 | 23,185 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $801,886 | 10,572 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $676,880 | 10,171 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,811,270 | 28,804 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,700,081 | 30,182 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,205,357 | 29,206 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,283,688 | 28,443 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,577,597 | 25,347 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||